tempus AI Inc Class A call volume above normal and directionally bullish
Bullish option flow detected in tempus AI ( TEM) Inc Class A with 59,111 calls trading, 4x expected, and implied vol increasing almost 6 points to 93.24%. 2/14 weekly 80 calls and Feb-25 85 calls are ...
William Blair Downgrades Tempus AI, Inc. (TEM) to Market Perform on Valuation Concerns
We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...
Tempus AI enters collaboration with Institute for Follicular Lymphoma Innovation
Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...
Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Think It's Too Late to Buy Tempus AI Stock? Here's the Biggest Reason Why There's Still Time.
Refusing to slow down since the start of the new year, shares of Tempus AI (NASDAQ: TEM) have skyrocketed nearly 99% since ...
Tempus AI, Inc. (TEM): Among the Large-Cap Stocks Insiders Are Selling Recently
We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a ...
Tempus AI stock downgraded by William Blair after massive rally
William Blair downgraded Tempus AI Inc (NASDAQ:TEM) to "Market Perform" from "Outperform" given stock's sharp rally rather ...
Finbold | Finance in Bold1d
If you put $1,000 into Tempus AI stock when Nancy Pelosi bought, here’s your return now
Regarding the transaction, the lawmaker disclosed on January 14 the accumulation of 50 call options in Tempus AI with a ...
TMCnet2d
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...
TMCnet2d
Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, ...
Tempus AI (NASDAQ:TEM) & Sabre (NASDAQ:SABR) Head to Head Comparison
Sabre (NASDAQ:SABR – Get Free Report) and Tempus AI (NASDAQ:TEM – Get Free Report) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses ...